BEACHES ( VB Ed onemon22 Collaboration )
By: VB Ed
Read the original:
BEACHES ( VB Ed & onemon22 Collaboration ) – Video
By: VB Ed
Read the original:
BEACHES ( VB Ed & onemon22 Collaboration ) – Video
By: Malka Covin
Go here to read the rest:
Rihanna, Kanye West & Paul McCartney’s Illuminati Threesome in Four Five Seconds Secrets R – Video
By: Human Nature Love Freedom Contemporary Art Movement
By: Mayo Clinic
Oct. 3, 2013
Jon Cheetham, large animal surgeon and equine researcher at Cornell is part of a partnership with the McGowan Institute for Regenerative Medicine in Pittsburg.
Scientists at Cornells College of Veterinary Medicine are partnering with renowned human medicine innovators at the McGowan Institute for Regenerative Medicine in Pittsburgh to advance healing techniques and technologies for animals and humans.
The McGowan Institute and several College of Veterinary Medicine faculty members work on the potential of regenerative techniques such as tissue engineering, cellular therapies and artificial organ devices in repairing damaged tissues and organs. In the collaboration, professionals from both institutions exchange research, techniques and ideas to advance the science and application of tissue engineering and regenerative medicine across species.
This is a natural partnership, said Jon Cheetham, D.V.M., a large animal surgeon and equine researcher at Cornell. We have expertise in preclinical animal models of human disease and special resources for research like looking at laryngeal function over time in horses on a treadmill or taking MRIs of the temporomandibular joint in pigs. We also have experts in developmental biology. Thats important because aspects of regenerative medicine attempt to mimic the early stages of development, when true regeneration, not just repair, can happen.
The research partnership has already spawned shared grant funding. For example, Cheetham and McGowan co-investigators have just received a three-year National Institutes of Health grant to explore new techniques for improving nerve repair, to heal debilitating nerve injuries in people and restore laryngeal function in people, dogs and horses.
Cornell and McGowan scientists also work together to use regeneration techniques in the meniscus, a jaw joint in which tears can affect chewing and speech.
In August, Stephen Badylak, D.V.M., Ph.D., M.D., deputy director of the McGowan Institute, was the keynote speaker at Cornells daylong 10th Annual Biological and Biomedical Sciences Graduate Program Symposium, explaining to an audience of about 90 students and researchers the science behind his groundbreaking advances in regenerative medicine. Other collaborative activities since 2011, when the partnership began, have included retreats, educational exchanges, continuing education and other research partnerships.
See more here:
Partnership homes in on regenerative medicine
IRVINE, Calif.–(BUSINESS WIRE)–
LIBERTY Dental Plan (LIBERTY) is pleased to announce that Dr. Gary Dougan, has joined LIBERTY Dental Plan as its National Dental Director.
It is an honor to have Dr. Dougan join our executive management team, and we look forward to this great partnership, said Dr. Amir Neshat, LIBERTYS CEO and founder. As the head of our national Quality Management and Utilization Management units, Dr. Dougan will undoubtedly bring a wealth of experience and knowledge that will contribute to advancing our commitment to providing members with exceptional oral healthcare. We cant wait to see how far this collaboration takes us.
As a seasoned specialist who has audited hundreds of offices and reviewed thousands of claims, Dr. Gary Dougan brings over 20 years of Dental Director and Quality Management experience to LIBERTY. He is a Certified Dental Auditor from the California Association of Dental Plans, and a Certified Dental Consultant from the American Association of Dental Consultants. He has been involved in dental insurance plan design, policy setting, regulatory compliance, and resolves member grievances and provider disputes. Dr. Dougan also owned and operated a multi-practitioner private practice in Oakland, practicing for over 20 years.
Dr. Dougan has formerly served as President of the Alameda County Dental Society and its charitable foundation, a recent Trustee of the California Dental Association, and past Chair of the CDA Leadership Development Committee, as well as an ADA Delegate. Dr. Dougan is a known national speaker on clinical topics as well as dental benefits industry issues, and serves on the board of a charitable foundation.
Dr. Dougan graduated from Georgetown University School of Dentistry in Washington, DC, and has a Master of Public Health degree from UCLA. He completed a General Practice Residency at LA County-USC Medical Center and was one of the first dentists chosen to participate in the UCSF Healthcare Leadership Fellowship with physicians, nurse administrators and other healthcare business leaders.
About LIBERTY Dental Plan
LIBERTY Dental Plan specializes in commercial and government sponsored dental programs, providing services to managed care organizations, state governments, labor unions, large group employers, municipalities, and individuals. With a vast majority of its membership enrolled in government sponsored programs, LIBERTY is recognized as a specialist in administering dental care for Medicaid, SCHIP and Medicare beneficiaries. LIBERTY has a proven record of successfully increasing the utilization of quality dental care for multiple programs, ensuring that a larger portion of premiums are appropriated directly to care.
LIBERTY Dental Plan is also recognized as an industry leader in the area of Dental Disease Management. A member of The Care Continuum Alliance (carecontinuum.org), LIBERTY shares their commitment to promote high quality standards for and definitions of key components of wellness, disease, case management where appropriate, and care coordination programs as well as support services and materials.
LIBERTY, Mo., June 11, 2013 /PRNewswire/ –In order to enhance the patient experience and allow for another convenient location, LasikPlus, a leading provider of laser vision correction is adding a second Kansas City-area vision center in the Fairway Eye Center located at 1528 NE 96th Street, Suite A in Liberty, Missouri.
Dr. Ellis and his staff will be conducting pre-operative examinations and post-operative care at the new location while still performing laser vision correction at the existing area Kansas City LasikPlus center in Leawood, KS.
According to Dr. Ellis, the space provides convenience and creates a comforting experience for patients. “I take pleasure in being part of the patient journey. Whether they are preparing for a laser vision correction treatment or coming in for a follow-up, it’s exciting to see each patient’s enthusiasm for their new vision.”
Dr. Ellis has performed over 50,000 LASIK and PRK procedures, making him one of the most experienced LASIK surgeons in the Midwest. Dr. Ellis is well-known for his published research on corneal surgery and has lectured on LASIK surgery at various ophthalmology training programs. With his knowledge, the collaboration between ophthalmologists and optometrists within the LasikPlus exclusive network, and the sophisticated equipment utilized, Dr. Ellis at LasikPlus can transform the vision of his patients.
About LCA-Vision/LasikPlusLCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus brand, operates 56 LasikPlus vision centers in the United States: 50 full-service LasikPlus fixed-site laser vision correction centers and six pre- and post-operative LasikPlus satellite centers. Since 1991, we have performed over 1.2 million laser vision correction procedures at our vision centers.
See the rest here:
Liberty, MO-area LasikPlus Vision Center Opens to Better Serve Patients
Collaboration between PR and SEO teams can lead to new content, better publicity, and even new business. Here’s how to make it work.
Does your PR team know SEO best practices and vice versa?
PR and SEO teams share a common goal–to increase a brand’s presence in the marketplace–but they take different approaches. As a business grows, it can be easy to silo groups and overlook opportunities for collaboration. Forming stronger ties between these two teams can lead to new content, better publicity and even new business. Working with Julie Perrigan, Rise Interactive’s SEO manager, we outlined three areas for companies to begin their PR and SEO collaboration:
The goal of public relations is to create content, find opportunities to share it and to gain exposure for your organization through media, print and digital efforts. SEO should be a piece of that puzzle, not an afterthought. Creating quality content allows your PR department to promote your company, by providing an easy-to-follow path back to your site through relevant links in your content. But both teams need to share common ground in order to build a website’s authority and brand awareness.
Before your PR team creates or pitches a story, members of both SEO and PR teams should discuss key messages, targeted keywords, distribution tactics and overall goals for each team. Also, both teams should explore the content landscape, then brainstorm, and develop content that sets you apart from the competition.
With Google algorithm updates–such as Panda and Penguin–changing the landscape of SEO, there is a growing need for quality content and links in high-authority sites.
Building ongoing, mutually beneficial relationships can help create a more holistic strategy. PR and SEO both utilize relationships to promote websites and brands. While a PR department makes more personal relationships via phone or in-person, SEO groups can build and foster relationships online. Finding those key influencers within your industry and building relationships to obtain links is where SEO and Link Building is heading. Make certain your PR and SEO departments are sharing their media lists and relationship-building opportunities (both online and offline) with one another.
Relationships are instrumental in building a strong network of brand advocates and will provide the most value for your business. However, if your teams are uncoordinated, it can lessen their credibility and damage new and existing relationships.
The Perfect PR and SEO Relationship
See the original post:
Mp3 Jack Grillo And Ricardo Hernandez – Legendary Original Soundtrack – Video
Follow this link:
Over the last year, many debates have raged about whether SEOs should start referring to themselves as inbound marketers or a number of other broader disciplines. Many long-time members of the great church of SEO consider the very thought of calling themselves something different almost treasonous at first.
After stewing watching our industry evolve at its most rapid clip ever over the past year, a clear truth has emerged: the only way to consistently win at SEO todayand over the long runis to create high-quality content.
This isnt just the theory of one SEO, inbound marketer, or agency. Many have written about this subject.
In February of 2012, Andy Betts artfully predicted this shift in his article Future of SEO: Change, Convergence, Collaboration.
Like it or not, SEO has changed and its future relies upon a complex relationship with content marketing, social media, and collaborative technology.
Googleschanges over recent years, such asCaffeine andGoogle Panda updates, are mostly concerned with content and relevancy issues. GooglesSSL changes are driving many SEOs to change and adapt the way they work with a renewed focus on quality content, social media signals, and technology.
Yahoo and Bing have also moved away from technical SEO in favor of content marketing and social media.
It is telling that, despite the fact that this was written almost nine months ago, there many who still cling to the old ways of doing and measuring things.
Because, high-quality content is never easy to create, and its not cheap.
View original post here:
Stop Selling SEO Short
The-Dream has weighed in on rap's obsession with the Illuminati, claiming if it did exist, long-rumoured members like Jay-Z, Kanye West and Rihanna wouldn't be allowed to join.
According to the 'Umbrella' hitmaker, critics simply use Illuminati theories to take undermine the hard work successful artists put in.
Talking to The Life Files TV, The-Dream said: “Pretty funny, 'cause nobody really wants to give you credit for where you at.”
The producer also insists black people would never be allowed the chance to join such a supposedly powerful organisation in the first place.
“It's a 'higher' power and they just happened to give it to the black people, yeah right. Whatever,” the 34-year-old scoffed. “If there was an Illuminati, they wouldn't let black people in.”
The long-time Rihanna collaborator recently defended her decision to duet with Chris Brown on the remixes to Birthday Cake and Turn Up the Music, saying 'it's just music'.
Kim Kardashian pictured getting close to The-Dream at basketball game… Whitney Houston Pictured Laying In Casket In Shocking Image Published By Magazine
Jay-Z 'Disgusted' With Rihanna For Chris Brown Collaboration
Matt Barnes' Beef With Game Explodes On Twitter Over Gloria Govan Cheating Claims
Go here to see the original:
The-Dream: 'Black People Can't Join the Illuminati'
SUNRISE, Fla., Feb. 14, 2012 (GLOBE NEWSWIRE) — Bioheart, Inc. (BHRT.OB) announced today that it has acquired the worldwide exclusive rights to Ageless Regenerative Institute's adipose (fat) derived therapeutic cell technology for use in the cardiac field.
“The Ageless adipose stem cell technology will allow us to broaden our portfolio of product candidates for cardiac patients,” said Mike Tomas, President and CEO of Bioheart. “We have successfully treated patients in Mexico and now we are ready to expand into the US.”
Adipose tissue is readily available and has been shown to be rich in microvascular, myogenic and angiogenic cells. Bioheart has recently applied to the FDA to begin trials using adipose derived stem cells or LipiCell(TM) in patients with chronic ischemic cardiomyopathy. Transplantation of LipiCell(TM) will be accomplished through endocardial implantations with the MyoStar(TM) Injection Catheter under the guidance of the NOGA(R) cardiac navigation system by Biosense Webster, Inc. — A Johnson & Johnson Company.
Under the terms of the agreement, Bioheart will have a worldwide exclusive license to all of Ageless technology for use in the heart attack and heart failure markets. The agreement provides for upfront and milestone equity payments to Ageless.
Ageless' President and Chief Executive Officer, Dr. Sharon McQuillan, MD added, “We are excited about this collaboration with Bioheart, a leader in developing cell therapies for cardiovascular disease. Together with Bioheart, we can help to revolutionize cardiovascular medicine and improve the current standard of care for these patients.”
About Bioheart, Inc.
Bioheart is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry delivering cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. Bioheart's goals are to cause damaged tissue to be regenerated, when possible, and to improve a patient's quality of life and reduce health care costs and hospitalizations.
Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Its leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.
For more information on Bioheart, visit http://www.bioheartinc.com.
About Ageless Regenerative Institute, LLC
The Ageless Regenerative Institute (ARI) is an organization dedicated to the standardization of cell regenerative medicine. The Institute promotes the development of evidence-based standards of excellence in the therapeutic use of adipose-derived stem cells through education, advocacy, and research. ARI has a highly experienced management team with experience in setting up full scale cGMP stem cell manufacturing facilities, stem cell product development & enhancement, developing point-of-care cell production systems, developing culture expanded stem cell production systems, FDA compliance, directing clinical & preclinical studies with multiple cell types for multiple indications, and more. ARI has successfully treated hundreds of patients utilizing these cellular therapies demonstrating both safety and efficacy. For more information about regenerative medicine please visit http://www.agelessregen.com.
Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,” “anticipate,” “intend,” “could,” “would,” “estimate,” or “continue” or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2010, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2011.
Read more from the original source:
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology